This metabolite features a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 about 50% on the guardian drug. Plasma concentrations of this metabolite are about 40% of Individuals observed for sildenafil, so that the metabolite accounts for approximately 20% of sildenafil's pharmacologic results.The effect on one of many … Read More